P68. A new EGFR - EpCAM bispecific antibody enhances the efficacy of adoptive T-cell therapy in a murine gastric tumour model

Overview of attention for article published in Journal for Immunotherapy of Cancer, March 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (76th percentile)
Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

patent: 3 patents

Readers on

mendeley: 5 Mendeley

Summary Patents

So far, Altmetric has seen 3 patents that reference this research output.

PD1-CD28 FUSION PROTEINS AND THEIR USE IN MEDICINE

Application EP-3909972-A1

European Patent Office

IMPROVED ADOPTIVE T-CELL THERAPY

Application WO-2018002358-A1

World Intellectual Property Organisation (WIPO)

PD-1-CD28 FUSION PROTEINS AND THEIR USE IN MEDICINE

Application WO-2016203048-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.